Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy ...

Coave's proprietary ALIGATER platform enables specific retargeting of AAV vectors to human receptors via a one-step chemical conjugation of peptide-based ligands at the surface of the capsid, ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Knowledge on the genetic basis of Parkinson's disease has grown tremendously since the discovery of the first monogenic form, ...

A research team led by Prof. Zhou Rongbin from the University of Science and Technology of China (USTC) discovered the ...

Biotech firm Gilead Sciences has announced plans to voluntarily withdraw the US accelerated approval for Trodelvy ...

Current spatially resolved transcriptomic technologies often struggle to achieve the necessary resolution to analyze individual cells within tissues ...

Professor and Chair Department of Physiology and Cellular Biophysics, Columbia University, New York ...

The aim of this study is to explore the kidney-specific adaptive immune landscape in patients with active LN at the single-cell level. Methods We performed single-cell RNA/B cell receptor (BCR)/T cell ...

Opdivo showed a 52% progression-free survival advantage over Adcetris in newly diagnosed Hodgkin’s lymphoma, according to a ...

A new paper from Elham Azizi's lab and collaborators has been accepted for publication in Genome Research, marking a ...